Nasal involvement in allergic asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 12, 2003, Pages 1235-1243

  Braunstahl, G J ^a   Fokkens, W ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Allergic rhinitis; Asthma; Clinical expression; Link; Mucosal inflammation; Systemic interaction; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ACUTE DISEASE; ALLERGIC ASTHMA; ALLERGIC RHINITIS; CHRONIC INFLAMMATION; HUMAN; IMMUNOLOGY; LOWER RESPIRATORY TRACT; MUCOSA INFLAMMATION; NOSE DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SMELLING; SYSTEMIC CIRCULATION; UPPER RESPIRATORY TRACT;

ASTHMA; HUMANS; NASAL POLYPS; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS;

EID: 0345688167     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0105-4538.2003.00354.x     Document Type: Review

References (117)

1. TOGIAS A. Mechanisms of nose-lung interaction. Allergy 1999;54:94-105.
2. BACHERT C, HORMANN K, MOSGES R, RASP G, RIECHELMANN H, MULLER R et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003;58:176-191.
3. LUNDBACK B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998;28:3-10.
4. PEARCE N, PEKKANEN J, BEASLEY R. How much asthma is really attributable to atopy? Thorax 1999;54:268-272.
5. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994;49:1-34.
6. PEDERSEN PA, WEEKE ER. Asthma and allergic rhinitis in the same patients. Allergy 1983;38:25-29.
7. MYGIND N, DAHL R, PEDERSEN S, Thestrup-Pedersen. atopic diseases. Essential allergy, 1st edn. Oxford: Blackwell Science Ltd, 1996:197-201.
8. MYGIND N, DAHL R, BACHERT C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 2000;55:S79-S83.
9. BRESCIANI M, PARADIS L, DES ROCHES A, VERNET H, VACHIER I, GODARD P et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001;107: 73-80.
10. TSAO CH, CHEN LC, YEH KW, HUANG JL. Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness. Chest 2003;123:757-764.
11. LAMBLIN C, GOSSET P, SALEZ F, VANDEZANDE LM, PEREZ T, DARRAS J et al. Eosinophilic airway inflammation in nasal polyposis. J Allergy Clin Immunol 1999;104:85-92.
12. STEVENS WJ, VERMEIRE PA, VAN SCHIL LA. Bronchial hyperreactivity in rhinitis. Eur J Respir Dis Suppl 1983;128:72-80.
13. UPTON MN, MCCONNACHIE A, MCSHARRY C, HART CL, SMITH GD, GILLIS CR et al. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ 2000;321:88-92.
14. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
15. DANIELSSON J, JESSEN M. The natural course of allergic rhinitis during 12 years of follow-up. Allergy 1997;52:331-334.
16. GREISNER WA, 3rd, SETTIPANE RJ, SETTIPANE GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19:185-188.
17. LEYNAERT B, NEUKIRCH F, DEMOLY P, BOUSQUET J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106:S201-S205.
18. TEN BRINKE A, GROOTENDORST DC, SCHMIDT JT, DE BRUINE FT, VAN BUCHEM MA, STERK PJ et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002;109:621-626.
19. RAMSDALE EH, MORRIS MM, ROBERTS RS, HARGREAVE FE. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 1985;75:573-577.
20. BRAMAN SS, BARROWS AA, DECOTIIS BA, SETTIPANE GA, CORRAO WM. Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest 1987;91:671-674.
21. POSTMA DS, BLEECKER ER, AMELUNG PJ, HOLROYD KJ, XU J, PANHUYSEN CI et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333: 894-900.
22. GUERRA S, SHERRILL DL, MARTINEZ FD, BARBEE RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-425.
23. SHAPIRO GG. Role of allergy in sinusitis. Pediatr Infect Dis 1985;4: S55-S59.
24. BOULET LP. Asymptomatic airway hyperresponsiveness: a curiosity or an opportunity to prevent asthma? Am J Respir Crit Care Med 2003;167:371-378.
25. GODTHELP T, FOKKENS WJ, KLEINJAN A, HOLM AF, MULDER PG, PRENS EP et al. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation. Clin Exp Allergy 1996;26:677-688.
26. MOLLER GM, OVERBEEK SE, VAN HELDEN-MEEUWSEN CG, VAN HAARST JM, PRENS EP, MULDER PG et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996;26:517-524.
27. BOUSQUET J, CHANEZ P, LACOSTE JY, BARNEON G, GHAVANIAN N, ENANDER I et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
28. CHANEZ P, VIGNOLA AM, VIC P, GUDDO F, BONSIGNORE G, GODARD P et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159:588-595.
29. HOWARTH PH. The cellular basis for allergic rhinitis. Allergy 1995;50:6-10.
30. MARCUCCI F, SENSI LG, MIGALI E, CONIGLIO G. Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen- allergic rhinitis and asthma. Allergy 2001;56:231-236.
31. PALCZYNSKI C, WALUSIAK J, RUTA U, GORSKI P. Occupational asthma and rhinitis due to glutaraldehyde: changes in nasal lavage fluid after specific inhalatory challenge test. Allergy 2001;56:1186-1191.
32. BENTLEY AM, JACOBSON MR, CUMBERWORTH V, BARKANS JR, MOQBEL R, Schwartz LB et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:877-883.
33. BRAUNSTAHL GJ, KLEINJAN A, OVERBEEK SE, PRINS JB, HOOGSTEDEN HC, FOKKENS WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161:2051-2057.
34. BRAUNSTAHL GJ, OVERBEEK SE, KLEINJAN A, PRINS JB, HOOGSTEDEN HC, FOKKENS WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469-476.
35. WARDLAW AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999;104: 917-926.
36. LEE BJ, NACLERIO RM, BOCHNER BS, TAYLOR RM, LIM MC, BAROODY FM. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol 1994;94:1006-1016.
37. LUSTER AD, ROTHENBERG ME. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 1997;62:620-633.
38. MATTHEWS AN, FRIEND DS, ZIMMERMANN N, SARAFI MN, LUSTER AD, PEARLMAN E et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 1998;95:6273-6278.
39. VAN DE RIJN M, MEHLHOP PD, JUDKINS A, ROTHENBERG ME, LUSTER AD, OETTGEN HC. A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin. J Allergy Clin Immunol 1998;102:65-74.
40. INMAN MD, ELLIS R, WATTIE J, DENBURG JA, O'BYRNE PM. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 1999;21:473-479.
41. PALFRAMAN RT, COLLINS PD, WILLIAMS TJ, RANKIN SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998;91:2240-2248.
42. BRIGHTLING CE, BRADDING P, SYMON FA, HOLGATE ST, WARDLAW AJ, PAVORD ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-1705.
43. DJUKANOVIC R, ROCHE WR, WILSON JW, BEASLEY CR, TWENTYMAN OP, HOWARTH RH et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
44. FORESI A, LEONE C, PELUCCHI A, MASTROPASQUA B, CHETTA A, D'IPPOLITO R et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol 1997;100:58-64.
45. ALVAREZ MJ, OLAGUIBEL JM, GARCIA BE, RODRIQUEZ A, TABAR AI, URBIOLA E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 2000;55:355-362.
46. SEDGWICK JB, CALHOUN WJ, GLEICH GJ, KITA H, ABRAMS JS, SCHWARTZ LB et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-1281.
47. SEDGWICK JB, CALHOUN WJ, VRTIS RF, BATES ME, MCALLISTER PK, BUSSE WW. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 1992;149:3710-3718.
48. DJUKANOVIC R, LAI CK, WILSON JW, BRITTEN KM, WILSON SJ, ROCHE WR et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5:538-544.
49. GAGA M, LAMBROU P, PAPAGEORGIOU N, KOULOURIS NG, KOSMAS E, FRAGAKIS S et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30:663-669.
50. CORREN J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997;99:S781-S786.
51. DUNLOP G, SCADDING GK, LUND VJ. The effect of endoscopic sinus surgery on asthma: management of patients with chronic rhinosinusitis, nasal polyposis, and asthma. Am J Rhinol 1999;13:261-265.
52. IKEDA K, TANNO N, TAMURA G, SUZUKI H, OSHIMA T, SHIMOMURA A et al. Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol 1999;108:355-359.
53. MCLANE ML, NELSON JA, LENNER KA, HEJAL R, KOTARU C, SKOWRONSKI M et al. Integrated response of the upper and lower respiratory tract of asthmatic subjects to frigid air. J Appl Physiol 2000;88:1043-1050.
54. LAMBLIN C, BRICHET A, PEREZ T, DARRAS J, TONNEL AB, WALLAERT B. Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 2000;161:406-413.
55. ASSANASEN P, BAROODY FM, NAURECKAS E, SOLWAY J, NACLERIO RM. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med 2001;164:1640-1646.
56. HELLGREN J, TOREN K, BALDER B, PALMQVIST M, LOWHAGEN O, KARLSSON G. Increased nasal mucosal swelling in subjects with asthma. Clin Exp Allergy 2002;32:64-69.
57. WOOD RA, EGGLESTON PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 1995;151:315-320.
58. CORREN J, ADINOFF AD, IRVIN CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992;89:611-618.
59. BARDIN PG, VAN HEERDEN BB, JOUBERT JR. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990;86:82-88.
60. UNDEM BJ, MCALEXANDER M, HUNTER DD. Neurobiology of the upper and lower airways. Allergy 1999;54:81-93.
61. STRAUSS RH, MCFADDEN ER JR, INGRAM RH JR, JAEGER JJ. Enhancement of exercise-induced asthma by cold air. N Engl J Med 1977;297:743-747.
62. STRAUSS RH, MCFADDEN ER JR, INGRAM RH JR, DEAL EC JR, JAEGER JJ. Influence of heat and humidity on the airway obstruction induced by exercise in asthma. J Clin Invest 1978;61:433-440.
63. GRIFFIN MP, MCFADDEN ER JR, INGRAM RH JR. Airway cooling in asthmatic and nonasthmatic subjects during nasal and oral breathing. J Allergy Clin Immunol 1982;69: 354-359.
64. NOLTE D, BERGER D. On vagal bronchoconstriction in asthmatic patients by nasal irritation. Eur J Respir Dis Suppl 1983;128:110-115.
65. ROSENBERG GL, ROSENTHAL RR, NORMAN PS. Inhalation challenge with ragweed pollen in ragweed-sensitive asthmatics. J Allergy Clin Immunol 1983;71:302-310.
66. SCHUMACHER MJ, COTA KA, TAUSSIG LM. Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma. J Allergy Clin Immunol 1986;78:30-35.
67. BRAUNSTAHL GJ, OVERBEEK SE, FOKKENS WJ, KLEINJAN A, MCEUAN AR, WALLS AF et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-865.
68. KROEGEL C, LIU MC, HUBBARD WC, LICHTENSTEIN LM, BOCHNER BS. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. J Allergy Clin Immunol 1994;93:725-734.
69. LITTELL NT, CARLISLE CC, MILLMAN RP, BRAMAN SS. Changes in airway resistance following nasal provocation. Am Rev Respir Dis 1990;141:580-583.
70. DENBURG JA, INMAN MD, WOOD L, ELLIS R, SEHMI R, DAHLBACK M et al. Bone marrow progenitors in allergic airways diseases: studies in canine and human models. Int Arch Allergy Immunol 1997;113:181-183.
71. SAITO H, HOWIE K, WATTIE J, DENBURG A, ELLIS R, INMAN MD et al. Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis. Immunology 2001;104:226-234.
72. DENBURG JA, INMAN MD, SEHMI R, UNO M, O'BYRNE PM. Hemopoietic mechanisms in allergic airway inflammation. Int Arch Allergy Immunol 1998;117:155-159.
73. WANG CH, HSIEH WY, SHIH LY, LIN HC, LIU CY, CHUNG KF et al. Increased progenitor cell proliferation in the peripheral blood of patients with bronchial asthma: the role of nitric oxide. J Allergy Clin Immunol 1999;104:803-810.
74. KIM YK, UNO M, HAMILOS DL, BECK L, BOCHNER B, SCHLEIMER R et al. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids. Am J Respir Cell Mol Biol 1999;20:388-397.
75. BRADLEY BL, AZZAWI M, JACOBSON M, ASSOUFI B, COLLINS JV, IRANI AM et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88: 661-674.
76. POLOSA R, CIAMARRA I, MANGANO G, PROSPERINI G, PISTORIO MP, VANCHERI C et al. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000;15:30-35.
77. CRIMI E, SPANEVELLO A, NERI M, IND PW, ROSSI GA, BRUSASCO V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9.
78. BRAUNSTAHL G, FOKKENS W, OVERSEEK S, KLEINJAN A, HOOGSTEDEN H, PRINS J. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy 2003;33:579-587.
79. BECKY KELLY EA, BUSSE WW, JARJOUR NN. A comparison of the airway response to segmental antigen bronchoprovocation in atopic asthma and allergic rhinitis. J Allergy Clin Immunol 2003;111:79-86.
80. WITTEMAN AM, SJAMSOEDIN DH, JANSEN HM, VAN DER ZEE JS. Differences in nonspecific bronchial responsiveness between patients with asthma and patients with rhinitis are not explained by type and degree of inhalant allergy. Int Arch Allergy Immunol 1997;112:65-72.
81. VAN DEN TOORN LM, OVERBEEK SE, DE JONGSTE JC, LEMAN K, HOOGSTEDEN HC, PRINS JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107-2113.
82. GLEICH GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
83. LOUIS R, LAU LC, BRON AO, ROLDAAN AC, RADERMECKER M, DJUKANOVIC R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
84. MARUYAMA N, TAMURA G, AIZAWA T, OHRUI T, SHIMURA S, SHIRATO K et al. Accumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individuals. Am J Respir Crit Care Med 1994;150:1086-1093.
85. PIPKORN U, KARLSSON G, ENERBACK L. Nasal mucosal response to repeated challenges with pollen allergen. Am Rev Respir Dis 1989;140:729-736.
86. JULIUSSON S, PIPKORN U, KARLSSON G, ENERBACK L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992;90:898-909.
87. FEATHER I, WILSON S. Eosinophils in rhinitis. In: BUSSE W, HOLGATE S, eds. Asthma and rhinitis, 1st edn. Oxford: Blackwell Scientific Publications, 1995:347-363.
88. MIADONNA A, MILAZZO N, GIBELLI S, SALMASO C, LORINI M, TEDESCHI A. Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours. Clin Exp Allergy 1999;29:941-949.
89. KLEINJAN A, MCEUEN AR, DIJKSTRA MD, BUCKLEY MG, WALLS AF, FOKKENS WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol 2000;106:677-686.
90. JEFFERY PK, WARDLAW AJ, NELSON FC, COLLINS JV, KAY AB. Bronchial biopsies in asthma, an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
91. KAWABORI S, NAKAMURA A, KANAI N. Tissue density and state of activation of eosinophils in the nasal mucosa of allergic and nonallergic rhinopathic patients. Allergy 1994;49:81-85.
92. CHETTA A, FORESI A, DONNO M, BERTORELLI G, PESCI A, OLIVIERI D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852-857.
93. BOULET LP, TURCOTTE H, LAVIOLETTE M, NAUD F, BERNIER MC, MARTEL S et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-1313.
94. CHAKIR J, LAVIOLETTE M, BOUTET M, LALIBERTE R, DUBE J, BOULET LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75;735-744.
95. SILVESTRI M, SABATINI F, SCARSO L, CORDONE A, DASIC G, ROSSI GA. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Allergy Immunol 2002;128:51-58.
96. OHNO I, NITTA Y, YAMAUCHI K, HOSHI H, HONMA M, WOOLEY K et al. Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am J Respir Cell Mol Biol 1995;13:639-647.
97. LI X, WILSON JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997;156:229-233.
98. ORSIDA BE, LI X, HICKEY B, THIEN F, WILSON JW, WALTERS EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999;54:289-295.
99. SALVATO G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001;56:902-906.
100. CARROLL NG, COOKE C, JAMES AL. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997;155:689-695.
101. GERGEN PJ, TURKELTAUB PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 1992;90:579-588.
102. KERKHOF M, SCHOUTEN JP, DE MONCHY JG. The association of sensitization to inhalant allergens with allergy symptoms: the influence of bronchial hyperresponsiveness and blood eosinophil count. Clin Exp Allergy 2000;30:1387-1394.
103. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-S334.
104. WELSH PW, STRICKER WE, CHU CP, NAESSENS JM, REESE ME, REED CE et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125-134.
105. FORESI A, PELUCCHI A, GHERSON G, MASTROPASQUA B, CHIAPPARINO A, TESTI R. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-282.
106. CORREN J, ADINOFF AD, BUCHMEIER AD, IRVIN CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90: 250-256.
107. LIPWORTH BJ, WHITE PS. Allergic inflammation in the unified airway: start with the nose. Thorax 2000;55:878-881.
108. AUBIER M, LEVY J, CLERICI C, NEUKIRCH F, HERMAN D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122-126.
109. KANAI N, DENBURG J, JORDANA M, DOLOVICH J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 1994;150:1094-1100.
110. HORWITZ RJ, MCGILL KA, BUSSE WW. The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med 1997;157: 1363-1371.
111. SAMPSON A, HOLGATE S. Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity. BMJ 1998;316:1257-1258.
112. BORISH L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 2002;88:16-22.
113. BUSSE W, CORREN J, LANIER BQ, MCALARY M, FOWLER-TAYLOR A, CIOPPA GD et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-190.
114. HOLGATE S, BOUSQUET J, WENZEL S, FOX H, LIU J, CASTELLSAGUE J. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality. Curr Med Res Opin 2001;17:233-240.
115. BOUSQUET J, GODARD P, MICHEL FB. Antihistamines in the treatment of asthma. Eur Respir J 1992;5: 1137-1142.
116. WOODCOCK A, CUSTOVIC A. ABC of allergies. Avoiding exposure to indoor allergens. BMJ 1998;316:1075-1078.
117. DURHAM SR, WALKER SM, VARGA EM, JACOBSON MR, O'BRIEN F, NOBLE W et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475.